Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by ESSNER ROBERT, Director. Officer active across 1 company, notably Amicus Therapeutics, INC.. Aggregated, 2 reports have been published. Activity tracked since 10 June 2021. The latest transaction was disclosed on 10 June 2021 (Attribution). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations
Robert Essner serves as a Board Member at AMICUS THERAPEUTICS, INC. He plays a key role in the governance of the company, bringing his expertise in biopharmaceuticals and product development. As a board member, he is involved in overseeing operations and strategic decision-making processes that influence Amicus's direction. His experience enables him to contribute to innovation and research in the healthcare sector.